根据韩国 (2015-2022) 制药经济评估豁免政策 (2015-2022) 对药品定价驱动因素的分析
1College of Pharmacy, Dong-Duk Women's University, Seoul, Republic of Korea.
Frontiers in pharmacology
|January 22, 2025
概括
韩国制药经济评估豁免 (PEE) 制度中的新药在2022年前显著增加. 较高的预算影响与较低的价格相关,这表明成本是PEE药物定价的关键因素.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 药品定价分析 药品定价分析
背景情况:
- 韩国的药物经济评估豁免 (PEE) 制度促进了新药的获取.
- 了解PEE系统中的药品定价决定因素对于政策和支出管理至关重要.
研究的目的:
- 分析在韩国PEE系统 (2015-2022) 中列出的新药物.
- 在PEE系统中确定影响药品定价决策的因素.
主要方法:
- 采用了一种混合方法的统计方法.
- 进行了描述性统计,t测试,皮尔森相关性和多重/等级回归分析.
- 药品价格的关键决定因素被确定和量化.
主要成果:
- 在2015年至2022年期间,在PEE系统中列出了30种新药.
- 到2022年,新药清单的显著增加被观察到.
- 在"KOR/A7最低"价格和预算影响之间发现了强烈的负相关性,表明更高的预算影响导致价格下降.
结论:
- 在韩国,PEE系统改善了患者获得新药的机会.
- 由于药品支出不断上升,预算影响是药品定价决策的一个重要因素.
- 需要进行政策调整和加强监督,以平衡成本控制和患者获取,可能通过分层风险共享协议.
相关概念视频
Analysis of Population Pharmacokinetic Data
222
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
222
Pharmacokinetic Models: Overview
573
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
573
Drug Control Governance: Regulatory Bodies and Their Impact
138
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
138
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
43
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
43
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
86
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
86
Prescription, Nonprescription and Orphan Drugs
684
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
684


